AUS
NZ
UK
CA
USA
IND
Health
Dynavax Technologies (NASDAQ:DVAX) Nasdaq 100 Index Healthcare Focus
December 24, 2025 12:00 AM PST| By Anmol KhazanchiDynavax Technologies (NASDAQ:DVAX) focuses on immune-based vaccine development through proprietary platforms, remaining visible in broader healthcare discussions associated with the nasdaq 100 index.
Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint
December 24, 2025 12:00 AM PST| By Anmol KhazanchiMerck & Co., Inc. operates as a global biopharmaceutical leader with strengths in oncology, vaccines, and animal health, maintaining visibility among major healthcare firms grouped within s&p 500 companies.
Medtronic plc (NYSE:MDT) S&P 500 Today Global Healthcare Presence
December 24, 2025 12:00 AM PST| By Anmol KhazanchiMedtronic plc (NYSE:MDT) operates as a global medical technology leader across devices and therapies, appearing in broader healthcare market discussions shaped by activity linked to s&p 500 today.
Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth
December 23, 2025 12:00 AM PST| By Anmol KhazanchiSoleno Therapeutics (NASDAQ:SLNO) focuses on precision medicine and rare disease research, maintaining visibility in broader healthcare discussions that appear alongside developments tracked in nasdaq today.
Simulations Plus Inc (NASDAQ:SLP) Nasdaq 100 Index Pharma Modeling
December 23, 2025 12:00 AM PST| By Team Kalkine MediaSimulations Plus (NASDAQ:SLP) delivers advanced modeling and simulation software for pharmaceutical and biotech research, appearing in broader market discussions connected to the nasdaq 100 index.
Syndax Pharmaceuticals (NASDAQ:SNDX) Nasdaq index Biotech Position
December 23, 2025 12:00 AM PST| By Anmol KhazanchiSyndax Pharmaceuticals (NASDAQ:SNDX) focuses on epigenetic oncology research through clinical-stage programs, appearing in biotechnology discussions shaped by activity across the nasdaq index.
Amicus Therapeutics (NASDAQ:FOLD) Nasdaq Futures Clinical Strategy
December 23, 2025 12:00 AM PST| By Anmol KhazanchiAmicus Therapeutics (NASDAQ:FOLD) develops treatments for rare diseases using pharmacological chaperones and gene therapy, appearing in broader biotech discussions shaped by nasdaq futures.
Tyra Biosciences (NASDAQ:TYRA) Nasdaq Composite ETF Biotech Research
December 23, 2025 12:00 AM PST| By Anmol KhazanchiTyra Biosciences (NASDAQ:TYRA) focuses on precision oncology through targeted small-molecule therapies for genetically defined cancers, remaining part of wider biotechnology discussions that include the Nasdaq Composite ETF.
Insmed Inc (NASDAQ:INSM) Nasdaq Today Anchors Clinical Innovation
December 23, 2025 12:00 AM PST| By Anmol KhazanchiInsmed (NASDAQ:INSM) develops targeted therapies for rare pulmonary diseases, remaining part of broader biotechnology discussions shaped by activity reflected in nasdaq today.
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq 100 Index Life Science Scope
December 23, 2025 12:00 AM PST| By Anmol KhazanchiMaravai LifeSciences (NASDAQ:MRVI) supplies reagents and services supporting genomics, diagnostics, and biologics development, appearing in broader biotechnology discussions connected to the nasdaq 100 index.
Novo Nordisk A/S (NYSE:NVO) Builds Global Therapeutic Depth
December 23, 2025 12:00 AM PST| By Anmol KhazanchiNovo Nordisk A/S (NYSE:NVO) is a global pharmaceutical company specializing in diabetes care and metabolic health, delivering therapies and research-driven solutions across international healthcare markets.
Eli Lilly and Company (NYSE:LLY) S&P 500 Chart Medical Scale
December 23, 2025 12:00 AM PST| By Anmol KhazanchiEli Lilly (NYSE:LLY) operates a global pharmaceutical platform spanning research, manufacturing, and healthcare delivery, frequently appearing in broader market discussions where the s&p 500 chart is cited.
Veeva Systems (NYSE:VEEV) Shares Rise on Life Sciences Software Demand
December 22, 2025 05:14 PM PST| By Anmol KhazanchiVeeva Systems (NYSE:VEEV) delivers cloud software solutions for life sciences, integrating Vault platform, regulatory compliance, workflow automation, and global operational efficiency.
Japan Approves Incyte’s (NASDAQ:INCY) Zynyz for First-Line Anal Cancer
December 22, 2025 02:53 AM PST| By Team Kalkine MediaHighlights,• Japan approves Zynyz with chemotherapy for first-line treatment of advanced anal cancer,• First approval for Zynyz in Japan and second globally for this indication,• Decision supported by Phase 3 POD1UM-303 clinical trial data,Incyte Bio...
Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus
December 22, 2025 12:00 AM PST| By Anmol KhazanchiAmgen Inc. (NASDAQ:AMGN) operates as a research-driven biotechnology company with global biologic manufacturing and distribution, frequently appearing in healthcare discussions connected to the nasdaq index.
Charles River (NYSE:CRL) S&P 500 Futures Safety Work
December 22, 2025 12:00 AM PST| By Anmol KhazanchiCharles River Laboratories delivers preclinical and clinical research services across pharmaceuticals and biotechnology, remaining visible in broader market conversations where s&p 500 futures are discussed.
Ginkgo Bioworks (NYSE:DNA) Expands Synthetic Biology Platform Scale
December 22, 2025 12:00 AM PST| By Anmol KhazanchiGinkgo Bioworks operates a platform-based synthetic biology model focused on engineering custom microorganisms through integrated laboratory automation, data systems, and scalable biological design services.
Stryker Advances Medical Technology with Innovative Solutions
December 19, 2025 08:23 AM PST| By Anmol KhazanchiStryker overview highlighting MedSurg and Orthopaedics operations, global manufacturing, technological innovation, quality standards, sustainability initiatives, and integrated healthcare solutions.
AMN Healthcare Services (NYSE:AMN) Shares Little Changed Today
December 19, 2025 07:24 AM PST| By Anmol KhazanchiDetailed exploration of AMN Healthcare Services operations, including nurse and physician staffing, technology integration, corporate structure, and regional healthcare service coverage.
Aclaris Therapeutics (NASDAQ:ACRS) Nasdaq Top 100 Biotech Model
December 19, 2025 12:00 AM PST| By Anmol KhazanchiAclaris Therapeutics (NASDAQ:ACRS) advances immune-focused clinical research, remaining visible in biotechnology discussions shaped by innovation themes associated with the nasdaq top 100.
